The ctDNA-RECIST Trial Part One

Clinical trial NCT06562348 · RECRUITING

Trial details

NCT number: NCT06562348
Sponsor: Karen-Lise Garm Spindler
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Neoplasm

Start date: 2025-01-15
Primary completion: 2029-09-01
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.